Search

Pages

1. • Journal article

   • 

   Standard Versus Intensified Chemotherapy With Granulocyte Colony-Stimulating Factor Support in Small-Cell Lung Cancer : A Prospective European Organization for Research and Treatment of Cancer–Lung Cancer Group Phase III Trial—08923

   Ardizzoni, Andrea Tjan-Heijnen, Vivianne C. G. Postmus, Pieter E. Buchholz, Erica Biesma, Bonne Karnicka-Mlodkowska, Hanna Dziadziusko, Rafal Burghouts, Jos Van Meerbeeck, Jan P. Gans, Stevens Legrand, Catherine[UCL] Debruynne, Channa Giaccone, Giuseppe (2002) Journal of Clinical Oncology — Vol. 20, no. 19, p. 3947-3955 (2002)
2. • Journal article

   • 

   A phase II study of paclitaxel in advanced bronchioloalveolar carcinoma (EORTC trial 08956)

   Scagliotti, Giorgio V. Smit, Egbert Bosquee, Lionel O'Brien, Mary Ardizzoni, Andrea Zatloukaf, Peter Eberhardt, Wilfried Smid-Geirnaerdt, Maartje de Bruin, Hein G. Dussenne, Sonia Legrand, Catherine[UCL] Giaccone, Giuseppe (2005) Lung Cancer — Vol. 50, no. 1, p. 91-96 (2005)
3. • Journal article

   • 

   A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials.

   Francart, Julie[UCL] Vaes, Evelien[UCL] Henrard, Séverine[UCL] Legrand, Catherine[UCL] Baas, P Gaafar, R. van Meerbeeck, J P Sylvester, Richard J.[UCL] Robert, Annie[UCL] (2009) European journal of cancer (Oxford, England : 1990) — Vol. 45, no. 13, p. 2304-11 (2009)
4. • Speech

   • 

   Surgery after induction chemotherapy: Morbidity and mortality in the first 100 patients of the surgery arm of EORTC 08941 trial

   Legrand, Catherine[UCL] (2003) 10th World Conference on Lung Cancer — Vancouver, Canada
5. • Journal article

   • 

   Progression-free survival rate as primary end point for phase II cancer clinical trials : application to mesothelioma--The EORTC Lung Cancer Group.

   Francart, Julie[UCL] Legrand, Catherine Sylvester, Richard Van Glabbeke, Martine van Meerbeeck, Jan P Robert, Annie[UCL] (2006) Journal of Clinical Oncology — Vol. 24, no. 19, p. 3007-12 (2006)
6. • Journal article

   • 

   EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)

   Ardizzoni, A Manegold, C Debruyne, C Gaafar, R Buchholz, E Dussenne, S Legrand, Catherine[UCL] King, K Giaccone, Giuseppe (2000) Lung Cancer — Vol. 29, no. suppl. 1, p. 51 (suppl. 2000)
7. • Speech

   • 

   Soluble mesothelin as a tool for early detection of malignant mesothelioma in asbestos-exposed workers

   Hollevoet, Kevin Van Cleemput, Joris Thimpont, Joel Vandeweerdt, Marc De Vuyst, Paul Nackaerts, Kristiaan[UCL] Delanghe, Joris Legrand, Catherine[UCL] van Meerbeeck, Jan P. (2009) —
8. • Journal article

   • 

   Quality assurance of thoracic radiotherapy in EORTC 08941: A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy

   Kramer, G.W.P.M. Legrand, Catherine[UCL] van Schil, Paul Uitterhoeve, Lon Smit, Egbert F. Schramel, Franz Biesma, Bonne Tjan-Heijnen, Vivianne van Zandwijk, Nico Splinter, Ted Giaccone, Giuseppe van Meerbeeck, Jan P. (2006) European Journal of Cancer — Vol. 42, no.10, p. 1391–1398 (July 2006)
9. • Speech

   • 

   Induction chemotherapy (CT) in stage IIIA-N2 non-small cell lung cancer (NSCLC): An analysis of different regimens used in EORTC 08941

   Legrand, Catherine[UCL] (2003) 10th World Conference on Lung Cancer — Vancouver, Canada
10. • Journal article

    • 

    Randomized Controlled Trial of Resection Versus Radiotherapy After Induction Chemotherapy in Stage IIIA-N2 Non–Small-Cell Lung Cancer

    van Meerbeeck, Jan P. Kramer, Gijs w.P.M. Van Schil, Paul E. Y. Legrand, Catherine[UCL] Smit, Egbert F. Schramel, Franz Tjan-Heijnen, Vivianne Biesma, Bonne Debruyne, Channa van Zandwijk, Nico Splinter, Ted A.W. Giaccone, Giuseppe (2007) Journal of the National Cancer Institute — Vol. 99, no.6, p. 442-450 (March 2007)
11. • Journal article

    • 

    Chronomodulation: optimal time finding design

    Baron, Benoit Legrand, Catherine[UCL] Levi, F. Hoctin-Boes, G. (2001) Controlled Clinical Trials — Vol. 22, no. suppl. 1, p. S59-S60 (2001)
12. • Journal article

    • 

    Long-Term Results of a Randomized Trial Comparing Breast-Conserving Therapy With Mastectomy : European Organization for Research and Treatment of Cancer 10801 Trial

    van Dongen, Joop A. Voogd, Adri C. Fentiman, Ian S. Legrand, Catherine[UCL] Sylvester, Richard J. Tong, David van der Schueren, Emmanuel Helle, Peter A. van Zijl, Kobus Bartelink, Harry (2000) Journal of the National Cancer Institute — Vol. 92, no. 14, p. 1143-1150 (2000)
13. • Journal article

    • 

    Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer : an EORTC phase II study (EORTC 08958)

    O'Brien, M.E.R. Splinter, T. Smit, E.F. Biesma, Bonne Krzakowski, M. Tjan-Heijnen, V.c.G Van Bochove, A. Stigt, J. Smid-Geirnaerdt, M.J.A. Debruyne, C. Legrand, Catherine[UCL] Giaccone, Giuseppe (2003) European Journal of Cancer — Vol. 39, no. 10, p. 1416-1422 (2003)
14. • Journal article

    • 

    Prognostic significance of PS6K in node-negative premenopausal breast cancer patients

    Van Der Hage, J.A. Robanus, E. van den Broeck, L.J.C.M. Bosch, C. van de Velde, C.J.H. Clahsen, P. Legrand, Catherine[UCL] Duchateau, L. van de Vijver, M.J. (2001) European Journal of Cancer — Vol. 37, no. suppl. 6, p. S269 (April 2001)
15. • Journal article

    • 

    Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi.

    Tromme, Isabelle Devleesschauwer, Brecht Beutels, Philippe Richez, Pauline Praet, Nicolas Sacré, Laurine Marot, Liliane[UCL] Van Eeckhout, Pascal[UCL] Theate, Ivan Baurain, Jean-François Lambert, Julien Legrand, Catherine[UCL] Thomas, Luc Speybroeck, Niko (2014) PLoS One — Vol. 9, no. 10, p. e109339 (2014)
16. • WorkingPaper

    • 

    A Bayesian framework for the ratio of two Poisson rates in the context of vaccine efficacy trials

    Laurent, Stéphane Legrand, Catherine[UCL] (2009)
17. • WorkingPaper

    • 

    Diagnostic performance of soluble mesothelin and megakaryocyte potentiating factor as biomarkers of mesothelioma

    Hollevoet, K. Kellen, E. Thimpont, J. Germonpré, P. De Vuyst, P. Bosquée, L. Legrand, Catherine[UCL] Kishi, Y. Nackaerts, K. Delanghe, J.R. Van Meerbeeck, J.P. (2009)
18. • WorkingPaper

    • 

    A randomized phase II study comparing two schedules of the 21-day regime of Gemcitabine and Carboplatin in advanced NSCLC

    Surmont, V. Aerts, J. Van Klaveren, R.J. Tournoy, K. Tan, K. Vernhout, R.M. Schmitz, P.I.M. Legrand, Catherine[UCL] Hoogsteden, H.C. Van Meerbeeck, J.P. (2009)
19. • Book

    • 

    Assessing Heterogeneity in Clinical Trials Using the Frailty Model : Quantifying, interpreting and explaining heterogeneity over centers in multicenter cancer clinical trials

    Legrand, Catherine[UCL] (2009)
20. • Journal article

    • 

    Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study

    Bottomley, Andrew Vincent, Marie-Françoise[UCL] Gaafa, R Manegold, C. Burgers, S Coens, Corneel Legrand, Catherine[UCL] Giaccone, Giuseppe van Meerbeeck, J. (2006) Journal of Clinical Oncology — Vol. 24, no. 9, p. 1435-1442 (2006)
21. • Journal article

    • 

    European Organization for Research and Treatment of Cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer

    Ardizzoni, A. Manegold, C. Debruyne, Channa[UCL] Gaafar, R. Buchholz, E. Smit, E. F. Lianes, P. ten Velde, G. Bosquée, L.[UCL] Legrand, Catherine[UCL] Neumaier, C. King, K. Giaccone, Giuseppe (2003) Clinical Cancer Research — Vol. 9, no. 1, p. 143-150 (2003)
22. • WorkingPaper

    • 

    Sample size in randomized clinical trials in oncology: usefull basic statistical knowledge for the clinician

    Meyer, Nicolas[UCL] Legrand, Catherine[UCL] Giaccone, Giuseppe (2009)
23. • Journal article

    • 

    Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients : an EORTC double-blind placebo-controlled phase III study

    Tjan-Heijnen, V.C.G. Postmus, P.E. Ardizzoni, A. Manegold, Ch. Burghouts, J. van Meerbeeck, J. Mollers, M. Gans, S. Buchholz, E. Biesma, Bonne Legrand, Catherine[UCL] Debruyne, C. Giaccone, Giuseppe (2001) Annals of Oncology — Vol. 12, no. 10, p. 1359-1368 (2001)
24. • Speech

    • 

    Soluble mesothelin as a monitoring tool in the management of malignant mesothelioma patients

    Hollevoet, Kevin Kellen, Eliane[UCL] Nackaerts, Kristiaan[UCL] Bosquee, Lionel Germonpre, Paul Delanghe, Joris Legrand, Catherine[UCL] van Meerbeeck, Jan P. (2009) —
25. • Journal article

    • 

    Overexpression of P70 S6 kinase protein is associated with increased risk of locoregional recurrence in node-negative premenopausal early breast cancer patients

    van der Hage, JA van den Broek, LJCM Legrand, Catherine[UCL] Clahsen, PC. Bosch, CJA Robanus-Maandag, EC van de Velde, CJH van de Vijver, MJ (2004) The British journal of cancer — Vol. 90, no. 8, p. 1543-1550 (2004)

Pages